Zaccardelli, Alessandra
Liu, Xinyi
Ford, Julia A.
Cui, Jing
Lu, Bing
Chu, Su H.
Schur, Peter H.
Speyer, Cameron B.
Costenbader, Karen H.
Robinson, William H.
Sokolove, Jeremy
Karlson, Elizabeth W.
Camargo, Carlos A. Jr
Sparks, Jeffrey A. https://orcid.org/0000-0002-5556-4618
Funding for this research was provided by:
National Institutes of Health (K23 AR069688)
National Institutes of Health (L30 AR066953)
National Institutes of Health (R01 AR049880)
National Institutes of Health (R01 AR059073)
National Institutes of Health (K24 AR052403)
National Institutes of Health (K24 AR 066109)
National Institutes of Health (UM1 CA176726)
National Institutes of Health (R01 CA049449)
National Institutes of Health (R01 CA067262)
National Institutes of Health (P30 AR070253)
National Institutes of Health (P30 AR072577)
Rheumatology Research Foundation (K Supplement Award)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R03 AR075886)
Article History
Received: 20 May 2019
Accepted: 17 October 2019
First Online: 21 November 2019
Ethics approval and consent to participate
: All components of this study were approved by the Partners HealthCare Institutional Review Board. Informed consent to participate was obtained from all individual participants.
: No individual-level data are contained in this report.
: Dr. Sokolove is currently an employee of GlaxoSmithKline.